KC
Therapeutic Areas
Mitera Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Placental Protein Program | Autoimmune disorders & Solid organ transplant rejection | Preclinical |
Leadership Team at Mitera Biosciences
SC
Stanley C. Jordan, MD
Co-founder & Chief Scientific Officer
SA
S. Ananth Karumanchi, MD
Co-founder & Lead Scientific Advisor
TN
Tom Neary
Head of Finance
KM
Kristin Mulready, MS, GCEC
Head of Program Management
SR
Scott Rudge, PhD
Head of CMC
AK
Amanda Kohler, PhD
Head of Protein Engineering